Clean ScienceQ2 FY24

Clean Science Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹715.95P/E: 32.6Market Cap: ₹7.6K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Target to increase HALS sales to 200 tons per month by March FY25, with new products from the series also expected to contribute significantly.
  • Non-flagship/new products now contribute 25% of revenues and expected to grow, gradually reducing flagship product revenue share.
  • Growth to be driven by volume increases from newer products, including TBHQ and DCC, which are seen as steady, non-cyclical demand products.
  • Internal accruals will finance new CAPEX, supported by cash reserves (~Rs. 250 crores).
  • Demand recovery expected to be gradual over the next 2-3 quarters, with volumes likely to improve from 2Q FY24 levels.
  • Company emphasizes diversification in products and geography which is aiding margin resilience despite volume/realization pressures.
  • Pricing likely to remain under pressure until China normalizes; market conditions and pricing trends will be clearer in coming quarters.

See what Clean Science management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • No new fundraising through debt or equity is planned currently.
  • All ongoing and planned CAPEX (~Rs. 300 crores through Clean Fino-Chem subsidiary and additional Rs. 170-180 crores for new products) will be fully funded through internal accruals.
  • The company has about Rs. 250 crores in cash on the balance sheet to support CAPEX requirements.
  • Management emphasized reliance on internal accruals for financing expansions and new projects without the need for external funding.

See what Clean Science management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Ongoing CAPEX of approximately Rs. 300 crores at Clean Fino-Chem Limited (CFCL), expected to commission by Q4 FY24, fully funded through internal accruals.
  • New pilot facility at CFCL to commission within next 4 weeks to aid scale-up from lab to commercial production.
  • Additional Rs. 170-180 crores earmarked for new products, announcement expected in next 1-2 quarters.
  • Rs. 250 crores investment planned starting January for HALS plant, sales expected to grow thereafter.
  • All new CAPEX and expansions to be financed through internal accruals; company currently holds Rs. 250 crores cash.
  • Rs. 30 crores CAPEX dedicated to pharma intermediate plant expected to generate Rs. 100 crores revenue, part of overall Rs. 200 crores multiproduct investment block.
  • Emphasis on state-of-the-art automated facilities to boost return on assets and reduce time to market.

Track Clean Science — get its next earnings analysis in your feed

How does Clean Science rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisClean Science
Rev 3Mar 3

How does Clean Science rank in Chemicals & Petrochemicals?

Compare Clean Science against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →